In mini-swine preliminary experiment, TXL reduced infarct size effectively when administered at high loading dose 3-h before ischemia [17] and even at low loading dose 1-h before ischemia [4], suggesting the biological effects of TXL could be reached within 1-h after i.g. delivered. Here, TXNL1 is linked to ischemia.